Form 4 for HAE HAEMONETICS CORP
Accepted 2023-07-20 00:00:00 ET · period of report 2023-07-18 · accession 0001127602-23-021080 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| DM | 2023-07-20 | 2023-07-18 | HAE | Llorens Josep | EVP, Gbl Manufacturing | M - OptEx | $57.10 | +4,928 | 20.9K | +31% | +$281.4K |
| D | 2023-07-20 | 2023-07-18 | HAE | Llorens Josep | EVP, Gbl Manufacturing | S - Sale+OE | $90.00 | -4,928 | 18.5K | -21% | -$443.5K |
| DM | 2023-07-20 | 2023-07-18 | HAE | Llorens Josep | EVP, Gbl Manufacturing | M - OptEx | $0.00 | -4,928 | 7,611 | -39% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2023-07-18 | M | A | 2,537 | $57.60 | 23,391 | D | — | — | (F2) This number includes unvested restricted stock units previously reported. |
| 2 | Common | Common Stock | 2023-07-18 | S | D | 4,928 | $90.00 | 18,463 | D | — | — | (F2) This number includes unvested restricted stock units previously reported. |
| 3 | Common | Common Stock | 2023-07-18 | M | A | 2,391 | $56.57 | 20,854 | D | — | — | (F2) This number includes unvested restricted stock units previously reported. |
| 4 | Derivative | Non-qualified Stock Option (Right to Buy) | 2023-07-18 | M | D | 2,391 | $0.00 | 4,782 | D | $56.57 · 2022-05-18 to 2028-05-18 | 2,391 Common Stock | (F3) Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. |
| 5 | Derivative | Non-qualified Stock Option (Right to Buy) | 2023-07-18 | M | D | 2,537 | $0.00 | 7,611 | D | $57.60 · 2023-05-16 to 2029-05-16 | 2,537 Common Stock | (F3) Option vests in annual increments of 25% beginning on the first anniversary of the date of grant. |